Page last updated: 2024-09-05
hmr 1766 and calcimycin
hmr 1766 has been researched along with calcimycin in 1 studies
Compound Research Comparison
Studies (hmr 1766) | Trials (hmr 1766) | Recent Studies (post-2010) (hmr 1766) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
---|---|---|---|---|---|
23 | 1 | 11 | 11,946 | 40 | 444 |
Protein Interaction Comparison
Protein | Taxonomy | hmr 1766 (IC50) | calcimycin (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 1.41 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Martinelli, AM; Moraes, TF; Rodrigues, CNDS; Rodrigues, GJ | 1 |
Other Studies
1 other study(ies) available for hmr 1766 and calcimycin
Article | Year |
---|---|
In Endothelial Cells, the Activation or Stimulation of Soluble Guanylyl Cyclase Induces the Nitric Oxide Production by a Mechanism Dependent of Nitric Oxide Synthase Activation.
Topics: Animals; Calcimycin; Cyclic GMP; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; ortho-Aminobenzoates; Rats; Rats, Wistar; Soluble Guanylyl Cyclase; Structure-Activity Relationship; Sulfonamides | 2018 |